NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MeiraGTx Holdings plc (NASDAQ: MGTX)

 
MGTX Technical Analysis
5
As on 9th Jun 2023 MGTX STOCK Price closed @ 8.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.21 & Strong Sell for SHORT-TERM with Stoploss of 17.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MGTXSTOCK Price

Open 8.03 Change Price %
High 8.35 1 Day 0.03 0.37
Low 7.68 1 Week 1.49 22.64
Close 8.07 1 Month 2.78 52.55
Volume 152267 1 Year -12.95 -61.61
52 Week High 23.74 | 52 Week Low 5.04
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
MGTX
Daily Charts
MGTX
Intraday Charts
Whats New @
Bazaartrend
MGTX
Free Analysis
 
MGTX Important Levels Intraday
RESISTANCE9.36
RESISTANCE8.95
RESISTANCE8.69
RESISTANCE8.44
SUPPORT7.70
SUPPORT7.45
SUPPORT7.19
SUPPORT6.78
 
MGTX Forecast May 2024
4th UP Forecast25.7
3rd UP Forecast20.05
2nd UP Forecast16.55
1st UP Forecast13.06
1st DOWN Forecast3.08
2nd DOWN Forecast-0.41
3rd DOWN Forecast-3.91
4th DOWN Forecast-9.56
 
MGTX Weekly Forecast
4th UP Forecast14.06
3rd UP Forecast12.14
2nd UP Forecast10.95
1st UP Forecast9.76
1st DOWN Forecast6.38
2nd DOWN Forecast5.19
3rd DOWN Forecast4.00
4th DOWN Forecast2.08
 
MGTX Forecast2024
4th UP Forecast46.84
3rd UP Forecast34.41
2nd UP Forecast26.72
1st UP Forecast19.04
1st DOWN Forecast-2.9
2nd DOWN Forecast-10.58
3rd DOWN Forecast-18.27
4th DOWN Forecast-30.7
 
 
MGTX Other Details
Segment EQ
Market Capital 979359296.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MGTX Address
MGTX
 
MGTX Latest News
 
Your Comments and Response on MeiraGTx Holdings plc
 
MGTX Business Profile
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was incorporated in 2015 and is based in New York, New York. Address: 430 East 29th Street, New York, NY, United States, 10016
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service